Consumer Information for: ACT MEMANTINE
Consumer Information
Information about the product including what the product is used for, dosage, warnings, proper use and side effects. This summary will not tell you everything about the product. Contact your healthcare professional if you have any questions about the product.
What the medication is used for
ACT Memantine has been prescribed to you, by a doctor to relieve symptoms of Alzheimer’s disease.
What it does
The brain contains N-methyl-D-aspartate (NMDA) receptors that are involved in transmitting nerve signals and may be important for learning and memory. Abnormal transmission of nerve signals through NMDA-receptors in the brain may affect memory and other mental functions and contribute to symptoms of Alzheimer’s disease. ACT Memantine belongs to a group of medicines called NMDA-receptor antagonists. The action of ACT Memantine on NMDA-receptors may help normalize the transmission of nerve signals, which may help slow the decline in some of the symptoms of Alzheimer disease.
When it should not be used
- You should not be taking ACT Memantine if you are pregnant, unless in the opinion of the doctor, the expected benefit to the patient markedly outweighs the possible hazards to the foetus.
- You should not be taking ACT Memantine if you are breastfeeding.
- Do not take ACT Memantine if you are allergic to it, or to any of the other ingredients listed in this leaflet (see ‘What the nonmedicinal ingredients are’).
- Stop taking ACT Memantine if you experience an allergic reaction or any severe side effect.
What the medicinal ingredient is
Memantine hydrochloride
What the non-medicinal ingredients are
Microcrystalline cellulose, magnesium stearate, titanium dioxide, lactose monohydrate, polyethylene glycol and hydroxypropyl methylcellulose.
What dosage form it comes in
5 mg and 10 mg tablets.
Warnings and precautions
BEFORE you use ACT Memantine talk to your doctor or pharmacist if:
- You have/had a medical condition, including heart problems, uncontrolled hypertension (high blood pressure), history of seizures or kidney disease
- You are taking any medications (prescription or non-prescription) or have taken any within the last 14 days.
- You ever had an allergic reaction to any medication
- You are pregnant or thinking of becoming pregnant, or if you are breast-feeding.
- There are conditions which can change the speed at which the body would normally eliminate the drug over time and you should tell your doctor, as ACT Memantine dosage may have to be adjusted if:
- You have recently changed or intend to change your diet substantially (e.g. from normal diet to strict vegetarian diet)
- You are suffering from renal tubulary acidosis (RTA, an excess of acid-forming substances in the blood due to renal dysfunction [kidney problems])
- You have a urinary tract infection
Interactions with this medication
Drugs that may interact with ACT Memantine include:
- NMDA-receptor antagonists (e.g. amantadine)
- Cimetidine
- Ranitidine
- Procainamide
- Quinidine
- Quinine
- Hydrochlorothiazide (or any combination with hydrochlorothiazide
- Anticholinergics (generally used to treat movement disorders or intestinal cramps)
- L-dopa and dopaminergic agonists (drugs such as bromocriptine, ropinirole, pramipexole)
- Ketamine
- Dextromethorphan (found in cough syrup labelled DM)
- Anticoagulant (blood thinner) medications taken by mouth
Proper use of this medication
Usual Dose
- It is important that you take ACT Memantine exactly as your doctor has instructed.
- Usually your doctor will prescribe 20 mg per day, which you will take as two separate doses of 10 mg. In order to reduce the risk of side effects this dose will be achieved gradually by the following daily treatment scheme, starting at a dose of 5 mg per day:
| AM | PM | |
| Week 1 | 1 x 5 mg tablet | None |
| Week 2 | 1 x 5 mg tablet | 1 x 5 mg tablet |
| Week 3 | 1 x 10 mg tablet | 1 x 5 mg tablet |
| Week 4 and beyond | 1 x 10 mg tablet | 1 x 10 mg tablet |
- Never change the dose of ACT Memantine unless your doctor tells you to.
- Swallow the tablets whole with some water. Do not chew tablets. ACT Memantine can be taken with or without food.
- Continue to take ACT Memantine as long as directed by your doctor and you do not experience any unacceptable side effects. Your doctor should assess your treatment on a regular basis.
Overdose
Missed Dose
- If you miss a dose, do not worry. Do not take the missed tablet(s) – just take the next dose when it is due.
Side effects and what to do about them
Like all medicines, ACT Memantine can cause side effects, although not everybody gets them. In general, these are mild to moderate. If any of the side effects become severe or if they are troublesome or persistent, talk to your doctor.
Common side effects (affects 1 to 10 users in 100) may include:
- headache
- sleepiness
- constipation
- tiredness
- confusion
- hallucinations (strange visions or sounds)
- vomiting
- loss of appetite
- dizziness
- sleep disturbance
- anxiety
- high blood pressure
- change in frequency of urination
Uncommon side effects (affects 1 to 10 users in 1000) may include:
- fungal infections
- changes in vision
Your doctor will tell you whether your illness allows you to drive
or operate machinery. Also, as this product may cause sleepiness
or dizziness, do not drive or operate machinery under these
conditions.
Alzheimer's disease has been associated with depression, thoughts
of suicide and suicide. These events have been reported in
patients treated with ACT Memantine.
If you have previously experienced epileptic seizures, there is a
possibility that ACT Memantine may increase the chances of one
occurring.
| Symptom / effect | Talk with your doctor, nurse, or pharmacist only if severe | Talk with your doctor, nurse, or pharmacist in all cases | Stop taking drug and seek immediate emergency treatment |
|---|---|---|---|
| Uncommon | |||
| Fungal infection | ✔ | ||
| Abnormal gait [Abnormal way of walking] | ✔ | ||
| Heart failure [persistent chest pain, rapid heart rate, severe shortness of breath, swelling of legs or ankles, increased tiredness, lack of appetite, confusion] | ✔ | ||
| Venous blood clotting [pain, swelling, changes in skin color, increased warmth in one leg] | ✔ | ||
| Very Rare | |||
| Seizures [loss of consciousness with uncontrollable shaking] | ✔ | ||
| Hepatitis/hepatic failure [yellow skin and eyes, nausea, loss of appetite, darkcoloured urine] | ✔ | ||
| serious skin reactions [rash, red skin, blistering of the lips, eyes or mouth, skin peeling] | ✔ | ||
| Inflammation of the pancreas [severe upper stomach pain, often with nausea and vomiting] | ✔ | ||
| psychotic reactions | ✔ | ||
This is not a complete list of side effects. For any unexpected effects while taking ACT Memantine contact your doctor or pharmacist.
If you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.
How to store
- As with all medicines, keep ACT Memantine out of the reach of children.
- Store your tablets at room temperature (15°C-30°C) and in a dry place.
- If your doctor tells you to stop taking your medicine you should return any leftover tablets to the pharmacist, unless the doctor tells you to keep them at home.
REMEMBER: This medicine is for YOU or for someone in your care. Only a doctor can prescribe it, so never offer it to any other person, even if their symptoms seem to be the same as yours or as for the person in your care.
Reporting side effects
You can report any suspected side effects associated with the use of health products to Health Canada by:
- Visiting the Web page on Adverse Reaction Reporting (https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/adverse-reaction-reporting.html) for information on how to report online, by mail or by fax; or Calling toll-free at 1-866-234-2345.
NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.
More information
This document plus the full product monograph, prepared for
health professionals can be found by contacting Teva Canada
Limited by:
Phone: 1-800-268-4127 ext. 3;
Email: druginfo@tevacanada.com; or
Fax: 1-416-335-4472
This leaflet was prepared by:
Teva Canada Limited
30 Novopharm Court
Toronto, Ontario
M1B 2K9
Canada
www.tevacanada.com
Last revised: April 3, 2020
Related Drug Products
| Product name | DIN | Company name | Active ingredient(s) & strength |
|---|---|---|---|
| TEVA-CYCLOSPORINE | 02462486 | TEVA CANADA LIMITED | CYCLOSPORINE 0.05 % / W/V |